Surveyor Capital - Massinvestor Venture Capital and Private Equity Database

HF Surveyor Capital

https://www.citadel.com/investment-strategies /surveyor-capital/

Office Locations:

300 Crescent Court, Suite 250
Dallas, TX 75201
Phone: 972-892-1700

Get all office locations for this firm with a National Database subscription or New York Database subscription.

Stages:

Early

Industries:

Life Sciences & Healthcare

Medical Device

Description:

Established in 2008, Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel Investment's three fundamental equities businesses. Surveyor's independent sector-aligned portfolio teams take a diligent, bottom-up investment approach. Citadel invests in companies in the Communications, Consumer, Energy, Financials, Healthcare, Industrials, Media and Entertainment, and Technology sectors.

Investment Firm Key

   VC = Venture Capital
   PE = Private Equity
   A = Angel
   I = Incubator
   MB = Merchant Bank
   VD = Venture Debt
   FI = Family Investment Office
   FOF = Fund of Funds
   ED = Economic Development Office
   TT = Technology Transfer Office
   CVC = Corporate Venture Capital
   SEC = Secondary Purchaser
   HF = Hedge Fund/Mutual Fund

COMPANY STAGE	REVENUE
Venture Capital
Seed Stage (includes "pre-seed," or concept stage)	No Revenue
Early Stage	Minimal Revenue
Growth Stage (also called Mid-stage)	$2M-$7M
Expansion Stage (also called Late-stage)	$7M and greater
Private Equity
Lower Middle Market	$10M-$249M
Middle Market	$250M-$499M
Upper Middle Market	$500M-$1B
Large Cap	>$1B

Click Here for a
FREE DEMO
of the #1 VC & PE
Database
>4,000 Firms
>18,000 Partners
>30,000 Portfolio
companies

Investment Team:

Name	Title	Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
Khalid Malik	Portfolio Manager
Rich Falk-Wallace	Portfolio Manager
Tariq Chaudhri	Portfolio Manager
Todd Barker	Head of Surveyor Capital

Recent Funding Events (trailing 12 months):

Date	Name	State	Amount	Stage
03/02/2021	Artiva Biotherapeutics	CA	$120,000,000	Series B
02/24/2021	Vividion Therapeutics	CA	$135,000,000	Series C
01/22/2021	Vera Therapeutics	CA	$80,000,000	Series C
01/19/2021	Verve Therapeutics	MA	$94,000,000	Series B
12/16/2020	Neuron23	CA	$113,500,000	Series A and B
11/09/2020	Decibel Therapeutics	MA	$82,000,000	Series D
10/06/2020	Talaris Therapeutics	MA	$115,000,000	Series B
09/17/2020	Palleon Pharmaceuticals	MA	$100,000,000	Series B
09/14/2020	ESCAPE Bio	CA	$73,000,000	Crossover Financing
08/27/2020	Kinnate Biopharma	CA	$98,000,000	Series C
08/10/2020	Dyne Therapeutics	MA	$115,000,000
08/07/2020	Aerovate Therapeutics	MA	$72,600,000	Series A
07/30/2020	Praxis Precision Medicines	MA	$110,000,000	Series C-1
07/24/2020	Olema Oncology	CA	$54,000,000	Series B
07/09/2020	VelosBio	CA	$137,000,000	Series B
07/02/2020	Bolt Biotherapeutics	CA	$93,500,000	Series C
07/02/2020	Annexon Biosciences	CA	$100,000,000	Venture
06/04/2020	Athira Pharma	WA	$85,000,000	Series B
03/30/2020	ElevateBio	MA	$170,000,000	Series B
03/03/2020	Pliant Therapeutics	CA	$100,000,000	Series C